The treatment of hemangioma of the larynx in children is still a dilemma
| Autor: | Aleksandra Simovic, Maja Vulovic, Dragan Milovanovic, Zlatan Elek, Stevan Stojanović, Katerina Dajic, Andjelka Stojkovic |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Larynx
vascular tissue child medicine.medical_specialty business.industry lcsh:R Corticosteroid treatment lcsh:Medicine General Medicine Propranolol medicine.disease Benign Vascular Neoplasm laryngeal disease Surgery Hemangioma medicine.anatomical_structure Epinephrine medicine Initial treatment Surgical treatment business neoplasm medicine.drug |
| Zdroj: | Srpski Arhiv za Celokupno Lekarstvo, Vol 147, Iss 3-4, Pp 226-229 (2019) |
| ISSN: | 2406-0895 0370-8179 |
| DOI: | 10.2298/sarh180209059s |
| Popis: | Introduction. The laryngeal hemangioma in children is a benign vascular neoplasm but it could become malignant after localization. Case outline. After two weeks of corticosteroid treatment in a 15-month-old boy, there were no desired results. This case report is a small contribution to the research of targeted Propranolol treatment in infantile laryngeal hemangioma and the role of Epinephrine in the initial treatment in life-threatening conditions. Conclusion. When laryngeal hemangioma has ?bad? localization and any surgical treatment is denied in spite of the vital risk, the choices of treatment are epinephrine (as the first choice) and propranolol. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|